↓ Skip to main content

Dove Medical Press

Article Metrics

Potential role of lampalizumab for treatment of geographic atrophy

Overview of attention for article published in Clinical Ophthalmology, June 2015
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (74th percentile)
  • High Attention Score compared to outputs of the same age and source (89th percentile)

Mentioned by

twitter
2 tweeters
patent
1 patent

Citations

dimensions_citation
19 Dimensions

Readers on

mendeley
29 Mendeley
Title
Potential role of lampalizumab for treatment of geographic atrophy
Published in
Clinical Ophthalmology, June 2015
DOI 10.2147/opth.s59725
Pubmed ID
Authors

Diana Do, William Rhoades, Drew Dickson

Abstract

The purpose of this article is to review the pathways underlying age-related macular degeneration and potential therapeutic targets, focusing on the complement pathway and the recent MAHALO Phase II trial of the investigational drug lampalizumab. This trial was the first to have shown positive results for the treatment of geographic atrophy in age-related macular degeneration. It has potential as a future treatment, and is currently undergoing a Phase III trial.

Twitter Demographics

The data shown below were collected from the profiles of 2 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 29 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 29 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 11 38%
Student > Ph. D. Student 4 14%
Student > Bachelor 4 14%
Other 2 7%
Student > Postgraduate 2 7%
Other 2 7%
Unknown 4 14%
Readers by discipline Count As %
Medicine and Dentistry 10 34%
Agricultural and Biological Sciences 7 24%
Biochemistry, Genetics and Molecular Biology 4 14%
Nursing and Health Professions 1 3%
Pharmacology, Toxicology and Pharmaceutical Science 1 3%
Other 1 3%
Unknown 5 17%

Attention Score in Context

This research output has an Altmetric Attention Score of 5. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 October 2019.
All research outputs
#4,212,959
of 15,942,222 outputs
Outputs from Clinical Ophthalmology
#270
of 2,232 outputs
Outputs of similar age
#61,137
of 238,034 outputs
Outputs of similar age from Clinical Ophthalmology
#8
of 75 outputs
Altmetric has tracked 15,942,222 research outputs across all sources so far. This one has received more attention than most of these and is in the 73rd percentile.
So far Altmetric has tracked 2,232 research outputs from this source. They receive a mean Attention Score of 3.5. This one has done well, scoring higher than 87% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 238,034 tracked outputs that were published within six weeks on either side of this one in any source. This one has gotten more attention than average, scoring higher than 74% of its contemporaries.
We're also able to compare this research output to 75 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 89% of its contemporaries.